id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-N-0477-0011,FDA,FDA-2010-N-0477,"Public Hearing on Approval Pathway for Biosimilar and Interchangeable Biological Products, 11/2/2010 Transcript",Other,TR-Transcript,2010-12-06T05:00:00Z,2010,12,2010-12-06T05:00:00Z,,2013-08-11T01:38:30Z,,0,0,0900006480bafe45
FDA-2010-N-0477-0012,FDA,FDA-2010-N-0477,"Public Hearing on Approval Pathway for Biosimilar and Interchangeable Biological Products, 11/3/2010 Transcript",Other,TR-Transcript,2010-12-06T05:00:00Z,2010,12,2010-12-06T05:00:00Z,,2013-08-11T01:38:30Z,,0,0,0900006480bafe46
FDA-2010-N-0477-0007,FDA,FDA-2010-N-0477,FDA/CDER/OMP - Testimony,Other,TS-Testimony,2010-11-09T05:00:00Z,2010,11,2010-11-09T05:00:00Z,,2013-07-27T23:36:38Z,,0,0,0900006480b816bc
FDA-2010-N-0477-0006,FDA,FDA-2010-N-0477,FDA/CDER/OMP - Testimony,Other,TS-Testimony,2010-11-09T05:00:00Z,2010,11,2010-11-09T05:00:00Z,,2013-08-11T04:42:48Z,,0,0,0900006480b811dd
FDA-2010-N-0477-0008,FDA,FDA-2010-N-0477,FDA/CDER/OMP - Testimony,Other,TS-Testimony,2010-11-09T05:00:00Z,2010,11,2010-11-09T05:00:00Z,,2013-07-27T23:36:35Z,,0,0,0900006480b81202
FDA-2010-N-0477-0002,FDA,FDA-2010-N-0477,"The Honorable Bernard Sanders to the FDA Comissioner of Food and Drugs, November 2, 2010 - Letter",Other,LET-Letter,2010-11-05T04:00:00Z,2010,11,2010-11-05T04:00:00Z,,2010-11-05T18:59:17Z,,0,0,0900006480b82f66
FDA-2010-N-0477-0001,FDA,FDA-2010-N-0477,Approval Pathway for Biosimilar and Interchangeable Biological Products; Hearing,Notice,NPH-Notice of Opportunity of Hearing,2010-10-05T04:00:00Z,2010,10,2010-10-05T04:00:00Z,2011-01-01T04:59:59Z,2024-11-07T22:25:35Z,2010-24853,1,0,0900006480b67c03